
PubMed:27342131 / 319-721
Annnotations
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T3 | 0-402 | Sentence | denotes | The goal of this review is to streamline 30 years of research and ask a set of important questions: in Type 1 diabetes which glycation products correlate best with 1) past mean glycemia 2) reversibility with improved glycemic control, 2) cross-sectional severity of retinopathy, nephropathy and neuropathy and 3) the future long-term risk of progression of micro- and subclinical macrovascular disease. |
T3 | 0-402 | Sentence | denotes | The goal of this review is to streamline 30 years of research and ask a set of important questions: in Type 1 diabetes which glycation products correlate best with 1) past mean glycemia 2) reversibility with improved glycemic control, 2) cross-sectional severity of retinopathy, nephropathy and neuropathy and 3) the future long-term risk of progression of micro- and subclinical macrovascular disease. |
pubmed-enju-pas
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
EnjuParser_T51 | 0-3 | DT | denotes | The |
EnjuParser_T52 | 4-8 | NN | denotes | goal |
EnjuParser_T53 | 9-11 | IN | denotes | of |
EnjuParser_T54 | 12-16 | DT | denotes | this |
EnjuParser_T55 | 17-23 | NN | denotes | review |
EnjuParser_T56 | 24-26 | VBZ | denotes | is |
EnjuParser_T57 | 27-29 | TO | denotes | to |
EnjuParser_T58 | 30-40 | VB | denotes | streamline |
EnjuParser_T59 | 41-49 | NNS | denotes | 30 years |
EnjuParser_T60 | 50-52 | IN | denotes | of |
EnjuParser_T61 | 53-61 | NN | denotes | research |
EnjuParser_T62 | 62-65 | CC | denotes | and |
EnjuParser_T63 | 66-69 | VB | denotes | ask |
EnjuParser_T64 | 70-71 | DT | denotes | a |
EnjuParser_T65 | 72-75 | NN | denotes | set |
EnjuParser_T66 | 76-78 | IN | denotes | of |
EnjuParser_T67 | 79-88 | JJ | denotes | important |
EnjuParser_T68 | 89-98 | NNS | denotes | questions |
EnjuParser_T69 | 98-99 | -COLON- | denotes | : |
EnjuParser_T70 | 100-102 | IN | denotes | in |
EnjuParser_T71 | 103-107 | NN | denotes | Type |
EnjuParser_T72 | 108-109 | CD | denotes | 1 |
EnjuParser_T73 | 110-118 | NN | denotes | diabetes |
EnjuParser_T74 | 119-124 | WDT | denotes | which |
EnjuParser_T75 | 125-134 | NN | denotes | glycation |
EnjuParser_T76 | 135-143 | NNS | denotes | products |
EnjuParser_T77 | 144-153 | VBP | denotes | correlate |
EnjuParser_T78 | 154-158 | JJS | denotes | best |
EnjuParser_T79 | 159-163 | IN | denotes | with |
EnjuParser_T80 | 164-165 | CD | denotes | 1 |
EnjuParser_T81 | 165-166 | -RRB- | denotes | ) |
EnjuParser_T82 | 167-171 | IN | denotes | past |
EnjuParser_T83 | 172-176 | JJ | denotes | mean |
EnjuParser_T84 | 177-185 | NN | denotes | glycemia |
EnjuParser_T85 | 186-187 | CD | denotes | 2 |
EnjuParser_T86 | 187-188 | -RRB- | denotes | ) |
EnjuParser_T87 | 189-202 | NN | denotes | reversibility |
EnjuParser_T88 | 203-207 | IN | denotes | with |
EnjuParser_T89 | 208-216 | VBN | denotes | improved |
EnjuParser_T90 | 217-225 | JJ | denotes | glycemic |
EnjuParser_T91 | 226-233 | NN | denotes | control |
EnjuParser_T92 | 233-234 | -COMMA- | denotes | , |
EnjuParser_T93 | 235-236 | CD | denotes | 2 |
EnjuParser_T94 | 236-237 | -RRB- | denotes | ) |
EnjuParser_T95 | 238-253 | JJ | denotes | cross-sectional |
EnjuParser_T96 | 254-262 | NN | denotes | severity |
EnjuParser_T97 | 263-265 | IN | denotes | of |
EnjuParser_T98 | 266-277 | NN | denotes | retinopathy |
EnjuParser_T99 | 277-278 | -COMMA- | denotes | , |
EnjuParser_T100 | 279-290 | NN | denotes | nephropathy |
EnjuParser_T101 | 291-294 | CC | denotes | and |
EnjuParser_T102 | 295-305 | NN | denotes | neuropathy |
EnjuParser_T103 | 306-309 | CC | denotes | and |
EnjuParser_T104 | 310-311 | LS | denotes | 3 |
EnjuParser_T105 | 311-312 | -RRB- | denotes | ) |
EnjuParser_T106 | 313-316 | DT | denotes | the |
EnjuParser_T107 | 317-323 | JJ | denotes | future |
EnjuParser_T108 | 324-333 | JJ | denotes | long-term |
EnjuParser_T109 | 334-338 | NN | denotes | risk |
EnjuParser_T110 | 339-341 | IN | denotes | of |
EnjuParser_T111 | 342-353 | NN | denotes | progression |
EnjuParser_T112 | 354-356 | IN | denotes | of |
EnjuParser_T113 | 357-363 | NN | denotes | micro- |
EnjuParser_T114 | 364-367 | CC | denotes | and |
EnjuParser_T115 | 368-379 | JJ | denotes | subclinical |
EnjuParser_T116 | 380-393 | JJ | denotes | macrovascular |
EnjuParser_T117 | 394-401 | NN | denotes | disease |
EnjuParser_R50 | EnjuParser_T52 | EnjuParser_T51 | arg1Of | goal,The |
EnjuParser_R51 | EnjuParser_T52 | EnjuParser_T53 | arg1Of | goal,of |
EnjuParser_R52 | EnjuParser_T55 | EnjuParser_T53 | arg2Of | review,of |
EnjuParser_R53 | EnjuParser_T55 | EnjuParser_T54 | arg1Of | review,this |
EnjuParser_R54 | EnjuParser_T52 | EnjuParser_T56 | arg1Of | goal,is |
EnjuParser_R55 | EnjuParser_T62 | EnjuParser_T56 | arg2Of | and,is |
EnjuParser_R56 | EnjuParser_T62 | EnjuParser_T57 | arg1Of | and,to |
EnjuParser_R57 | EnjuParser_T59 | EnjuParser_T58 | arg2Of | 30 years,streamline |
EnjuParser_R58 | EnjuParser_T59 | EnjuParser_T60 | arg1Of | 30 years,of |
EnjuParser_R59 | EnjuParser_T61 | EnjuParser_T60 | arg2Of | research,of |
EnjuParser_R60 | EnjuParser_T58 | EnjuParser_T62 | arg1Of | streamline,and |
EnjuParser_R61 | EnjuParser_T63 | EnjuParser_T62 | arg2Of | ask,and |
EnjuParser_R62 | EnjuParser_T65 | EnjuParser_T63 | arg2Of | set,ask |
EnjuParser_R63 | EnjuParser_T65 | EnjuParser_T64 | arg1Of | set,a |
EnjuParser_R64 | EnjuParser_T65 | EnjuParser_T66 | arg1Of | set,of |
EnjuParser_R65 | EnjuParser_T68 | EnjuParser_T66 | arg2Of | questions,of |
EnjuParser_R66 | EnjuParser_T68 | EnjuParser_T67 | arg1Of | questions,important |
EnjuParser_R67 | EnjuParser_T65 | EnjuParser_T69 | arg1Of | set,: |
EnjuParser_R68 | EnjuParser_T74 | EnjuParser_T69 | arg2Of | which,: |
EnjuParser_R69 | EnjuParser_T77 | EnjuParser_T70 | arg1Of | correlate,in |
EnjuParser_R70 | EnjuParser_T73 | EnjuParser_T70 | arg2Of | diabetes,in |
EnjuParser_R71 | EnjuParser_T73 | EnjuParser_T71 | arg1Of | diabetes,Type |
EnjuParser_R72 | EnjuParser_T73 | EnjuParser_T72 | arg1Of | diabetes,1 |
EnjuParser_R73 | EnjuParser_T76 | EnjuParser_T74 | arg1Of | products,which |
EnjuParser_R74 | EnjuParser_T76 | EnjuParser_T75 | arg1Of | products,glycation |
EnjuParser_R75 | EnjuParser_T76 | EnjuParser_T77 | arg1Of | products,correlate |
EnjuParser_R76 | EnjuParser_T78 | EnjuParser_T77 | arg2Of | best,correlate |
EnjuParser_R77 | EnjuParser_T77 | EnjuParser_T79 | arg1Of | correlate,with |
EnjuParser_R78 | EnjuParser_T103 | EnjuParser_T79 | arg2Of | and,with |
EnjuParser_R79 | EnjuParser_T80 | EnjuParser_T81 | arg1Of | 1,) |
EnjuParser_R80 | EnjuParser_T80 | EnjuParser_T82 | arg1Of | 1,past |
EnjuParser_R81 | EnjuParser_T99 | EnjuParser_T82 | arg2Of | ",",past |
EnjuParser_R82 | EnjuParser_T84 | EnjuParser_T83 | arg1Of | glycemia,mean |
EnjuParser_R83 | EnjuParser_T84 | EnjuParser_T85 | arg1Of | glycemia,2 |
EnjuParser_R84 | EnjuParser_T84 | EnjuParser_T86 | arg1Of | glycemia,) |
EnjuParser_R85 | EnjuParser_T84 | EnjuParser_T87 | arg1Of | glycemia,reversibility |
EnjuParser_R86 | EnjuParser_T84 | EnjuParser_T88 | arg1Of | glycemia,with |
EnjuParser_R87 | EnjuParser_T91 | EnjuParser_T88 | arg2Of | control,with |
EnjuParser_R88 | EnjuParser_T91 | EnjuParser_T89 | arg2Of | control,improved |
EnjuParser_R89 | EnjuParser_T91 | EnjuParser_T90 | arg1Of | control,glycemic |
EnjuParser_R90 | EnjuParser_T91 | EnjuParser_T92 | arg1Of | control,"," |
EnjuParser_R91 | EnjuParser_T93 | EnjuParser_T92 | arg2Of | 2,"," |
EnjuParser_R92 | EnjuParser_T93 | EnjuParser_T94 | arg1Of | 2,) |
EnjuParser_R93 | EnjuParser_T96 | EnjuParser_T95 | arg1Of | severity,cross-sectional |
EnjuParser_R94 | EnjuParser_T93 | EnjuParser_T96 | arg1Of | 2,severity |
EnjuParser_R95 | EnjuParser_T96 | EnjuParser_T97 | arg1Of | severity,of |
EnjuParser_R96 | EnjuParser_T98 | EnjuParser_T97 | arg2Of | retinopathy,of |
EnjuParser_R97 | EnjuParser_T84 | EnjuParser_T99 | arg1Of | glycemia,"," |
EnjuParser_R98 | EnjuParser_T101 | EnjuParser_T99 | arg2Of | and,"," |
EnjuParser_R99 | EnjuParser_T100 | EnjuParser_T101 | arg1Of | nephropathy,and |
EnjuParser_R100 | EnjuParser_T102 | EnjuParser_T101 | arg2Of | neuropathy,and |
EnjuParser_R101 | EnjuParser_T80 | EnjuParser_T103 | arg1Of | 1,and |
EnjuParser_R102 | EnjuParser_T109 | EnjuParser_T103 | arg2Of | risk,and |
EnjuParser_R103 | EnjuParser_T109 | EnjuParser_T104 | arg1Of | risk,3 |
EnjuParser_R104 | EnjuParser_T104 | EnjuParser_T105 | arg1Of | 3,) |
EnjuParser_R105 | EnjuParser_T109 | EnjuParser_T106 | arg1Of | risk,the |
EnjuParser_R106 | EnjuParser_T109 | EnjuParser_T107 | arg1Of | risk,future |
EnjuParser_R107 | EnjuParser_T109 | EnjuParser_T108 | arg1Of | risk,long-term |
EnjuParser_R108 | EnjuParser_T109 | EnjuParser_T110 | arg1Of | risk,of |
EnjuParser_R109 | EnjuParser_T111 | EnjuParser_T110 | arg2Of | progression,of |
EnjuParser_R110 | EnjuParser_T111 | EnjuParser_T112 | arg1Of | progression,of |
EnjuParser_R111 | EnjuParser_T114 | EnjuParser_T112 | arg2Of | and,of |
EnjuParser_R112 | EnjuParser_T113 | EnjuParser_T114 | arg1Of | micro-,and |
EnjuParser_R113 | EnjuParser_T117 | EnjuParser_T114 | arg2Of | disease,and |
EnjuParser_R114 | EnjuParser_T117 | EnjuParser_T115 | arg1Of | disease,subclinical |
EnjuParser_R115 | EnjuParser_T117 | EnjuParser_T116 | arg1Of | disease,macrovascular |
mondo_disease
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T2 | 103-118 | Disease | denotes | Type 1 diabetes | http://purl.obolibrary.org/obo/MONDO_0005147 |
T3 | 266-277 | Disease | denotes | retinopathy | http://purl.obolibrary.org/obo/MONDO_0005283 |
T4 | 279-290 | Disease | denotes | nephropathy | http://purl.obolibrary.org/obo/MONDO_0005240 |
T5 | 295-305 | Disease | denotes | neuropathy | http://purl.obolibrary.org/obo/MONDO_0005244 |
HP-phenotype
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T2 | 103-118 | Phenotype | denotes | Type 1 diabetes | HP:0100651 |
T3 | 266-277 | Phenotype | denotes | retinopathy | HP:0000488 |
T4 | 279-290 | Phenotype | denotes | nephropathy | HP:0000112 |
T5 | 295-305 | Phenotype | denotes | neuropathy | HP:0009830 |